Back
Alarum Technologies Vs. Kymera Therapeutics Industry Stock Comparison
Sell
32
ALAR
Alarum Technologies
Last Price:
10.87
Seasonality Move:
-24.08%
Buy
62
KYMR
Kymera Therapeutics
Last Price:
45.60
Seasonality Move:
25.63%
Sell
32
Alarum Technologies (ALAR)
is a Sell
Is Alarum Technologies a Buy, Sell or Hold?
- The current Alarum Technologies [ALAR] share price is $10.02. The Score for ALAR is 32, which is 36% below its historic median score of 50, and infers higher risk than normal.
- ALAR is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
62
Kymera Therapeutics (KYMR)
is a Buy
Is Kymera Therapeutics a Buy, Sell or Hold?
- The current Kymera Therapeutics [KYMR] share price is $46.88. The Score for KYMR is 62, which is 24% above its historic median score of 50, and infers lower risk than normal.
- KYMR is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
ALAR Stock Price Chart
What is Alarum Technologies's stock price today?
-
The Alarum Technologies share price today is $10.02
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and ALAR is experiencing slight selling pressure.
KYMR Stock Price Chart
What is Kymera Therapeutics's stock price today?
-
The Kymera Therapeutics share price today is $46.88
The current trend is moderately bearish and KYMR is experiencing buying pressure, which is a positive indicator for future bullish movement.
ALAR Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -3.94 | Sell |
Relative Strength Index (14 RSI): | 22.06 | Sell |
Chaikin Money Flow: | -63638 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (12.52 - 22.32) | Sell |
Bollinger Bands (100): | (19.48 - 36) | Sell |
KYMR Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 1.1 | Buy |
Relative Strength Index (14 RSI): | 55.23 | Buy |
Chaikin Money Flow: | 209294 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (42.77 - 48.09) | Buy |
Bollinger Bands (100): | (32.74 - 44.46) | Buy |
ALAR Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 11.44 | Sell |
20-day SMA: | 16.61 | Sell |
50-day SMA: | 24.34 | Sell |
200-day SMA: | 20.41 | Sell |
8-day EMA: | 11.77 | Sell |
20-day EMA: | 15.47 | Sell |
50-day EMA: | 21.24 | Sell |
200-day EMA: | 20.54 | Sell |
KYMR Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 46.77 | Buy |
20-day SMA: | 46.4 | Buy |
50-day SMA: | 42.99 | Buy |
200-day SMA: | 35.58 | Buy |
8-day EMA: | 46.64 | Buy |
20-day EMA: | 46.04 | Buy |
50-day EMA: | 43.26 | Buy |
200-day EMA: | 36.12 | Buy |
Alarum Technologies Earnings Growth & ALAR Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.53 per share, an increase next quarter of $0.01 per share, an increase this year of $2.02 per share, and an increase next year of $0.08 per share.
Kymera Therapeutics Earnings Growth & KYMR Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.15 per share, a decrease next quarter of $0.10 per share, a decrease this year of $0.25 per share, and a decrease next year of $0.51 per share.
Alarum Technologies Technical Analysis
Aug 27 | Aug 28 | Aug 29 | Aug 30 | Sep 3 | Sep 4 | Sep 5 | Sep 6 | Sep 9 | Sep 10 | |
---|---|---|---|---|---|---|---|---|---|---|
Aug | Sep | |||||||||
27 | 28 | 29 | 30 | 03 | 04 | 05 | 06 | 09 | 10 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Kymera Therapeutics Technical Analysis
Aug 27 | Aug 28 | Aug 29 | Aug 30 | Sep 3 | Sep 4 | Sep 5 | Sep 6 | Sep 9 | Sep 10 | |
---|---|---|---|---|---|---|---|---|---|---|
Aug | Sep | |||||||||
27 | 28 | 29 | 30 | 03 | 04 | 05 | 06 | 09 | 10 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |